New studies highlight that while persistent SARS-CoV-2 infections can evolve rapidly within individuals, they rarely spread onward. Meanwhile, the 2024–2025 COVID-19 vaccine reduced mortality by 64% among...
In this roundup, experts outline diverging pediatric COVID vaccine recommendations, midlife peaks in long COVID risk, new findings on abnormal uterine bleeding and cycle-related symptoms in long COVID, and...
In a randomized, placebo-controlled study, azelastine nasal spray significantly lowered the incidence of polymerase chain reaction-confirmed SARS-CoV-2 infections and reduced overall respiratory viral...
A pilot randomized trial found that offering immediate pre-exposure prophylaxis (PrEP) initiation with a 28-day starter pack in the emergency department did not improve PrEP use or retention compared with...
Managing HIV today means balancing speed, precision, and prevention. From deciding when to start antiretroviral therapy (ART) to optimizing follow-up labs and ensuring vaccine and prophylaxis coverage,...
This respiratory disease roundup covers the potential impact of a new COVID-19 variant, changes in funding for pandemic influenza vaccines, and a study on cardiac event risks in respiratory syncytial virus...
From respiratory syncytial virus monoclonal antibody approvals to thimerosal-free vaccine preferences, ACIP’s latest guidance has important implications for your practice.
Recurrent Clostridioides difficile infection remains a significant clinical challenge, with high rates of relapse and limited access to traditional FMT. Newly FDA-approved live biotherapeutic products offer...
A retrospective study finds that early surgical debridement in diabetic foot ulcers complicated by osteomyelitis significantly improves healing time, infection control, and amputation rates compared with...
